UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000006459
Receipt number	R000007666
Scientific Title	Phase II study of Erlotinib Plus Bevacizumab in patients with advanced Non-squamous and Non- Small Cell Lung Cancer not harboring EGFR mutation who failed to prior treatment (TAILORED-2 study)
Date of disclosure of the study information	2011/10/03
Last modified on	2011/10/03 12:55:02

---